新未名空间

Iris Medicine，pioneering a new RNA modality: small binding RNAs (sbRNAs). The sbRNA platform unlocks multiple therapeutic approaches, from allele-selective inhibition to gene activation to splicing modulation. 有朋友在这家公司吗？